Stock listing

LSE:TCF TheraCryf PLC Share Price

Home listing (LSE) of TheraCryf PLC

Follow TheraCryf PLC into a list and get an email when it puts out news.

Share price · LSE:TCF

0.17p GBX (pence) -0.00 (-2.9%)

Close on Oct 30, 2026

Past year -19.0% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
0.169p – 0.173p GBX (pence)Oct 30, 2026
Volume
6.38M sharesOct 30, 2026
Market cap
£3.65M GBPAt the close on Oct 30, 2026 · price × 2.15B shares outstanding
52-week range
0.16p – 0.268p GBX (pence)Lowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
£6,303 GBPMedian day 1.55M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
TheraCryf PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:TCF · Home0.17p GBX (pence)-0.005 (-2.9%)6,382,3470.173p0.173p0.169p0.175pClose on Oct 30, 2026
Frankfurt:8EV€0.0005 EUR0.0000 (0.0%)—€0.0005€0.0005€0.0005€0.0005Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · LSE:TCF · GBX (pence), adjusted for splits

DayCloseChange%OpenHighLowVolume
0.17p-0.005-2.9%0.173p0.173p0.169p6,382,347
0.175p0.000.0%0.175p0.175p0.17p577,411
0.175p0.000.0%0.175p0.176p0.17p48,191
0.175p0.000.0%0.175p0.177p0.175p566,572
0.175p0.000.0%0.175p0.177p0.17p12,087,688
0.175p0.000.0%0.175p0.178p0.175p2,812,681
0.175p-0.005-2.8%0.18p0.19p0.17p6,741,306
0.18p0.000.0%0.18p0.182p0.18p44,939
0.18p0.000.0%0.18p0.19p0.172p9,155,686
0.18p+0.005+2.9%0.18p0.19p0.17p2,385,729
0.175p0.000.0%0.175p0.177p0.171p6,123,002
0.175p0.000.0%0.175p0.177p0.171p3,499,213
0.175p0.000.0%0.175p0.175p0.175p30,741,215
0.175p-0.005-2.8%0.175p0.179p0.16p30,741,215
0.18p+0.01+5.9%0.18p0.18p0.17p15,301,111
0.17p-0.01-5.6%0.18p0.19p0.17p4,770,131
0.18p0.000.0%0.18p0.19p0.17p5,609,210
0.18p0.000.0%0.18p0.18p0.17p10,033
0.18p0.000.0%0.18p0.18p0.173p341,969
0.18p0.000.0%0.18p0.19p0.17p156,365
0.18p0.000.0%0.18p0.185p0.173p1,057,427
0.18p0.000.0%0.18p0.19p0.17p2,671,600
0.18p+0.005+2.9%0.18p0.19p0.18p4,007,428
0.175p+0.005+2.9%0.17p0.189p0.16p11,686,357
0.17p0.000.0%0.17p0.18p0.17p900,933
0.17p0.000.0%0.17p0.18p0.16p4,830,701
0.17p-0.005-2.9%0.175p0.18p0.17p2,531,885
0.175p0.000.0%0.175p0.175p0.175p1,204,465
0.175p0.000.0%0.175p0.18p0.17p1,204,465
0.175p0.000.0%0.175p0.18p0.175p3,777
0.175p-0.01-5.4%0.18p0.18p0.162p5,733,950
0.185p0.000.0%0.185p0.185p0.17p305,295
0.185p0.000.0%0.185p0.20p0.17p79,200
0.185p0.000.0%0.185p0.20p0.17p169,426
0.185p0.000.0%0.185p0.20p0.171p1,251,315
0.185p0.000.0%0.185p0.20p0.17p31,724
0.185p0.000.0%0.185p0.20p0.17p507,599
0.185p0.000.0%0.185p0.20p0.17p340,396
0.185p0.000.0%0.185p0.20p0.17p804,711
0.185p0.000.0%0.185p0.20p0.172p2,218,316
0.185p0.000.0%0.185p0.20p0.172p1,195,299
0.185p-0.005-2.6%0.19p0.20p0.18p4,374,025
0.19p0.000.0%0.19p0.19p0.18p593,023
0.19p0.000.0%0.19p0.20p0.18p405,000
0.19p0.000.0%0.19p0.195p0.18p1,799,771
0.19p0.000.0%0.19p0.20p0.18p668,009
0.19p0.000.0%0.19p0.20p0.18p1,531,057
0.19p0.000.0%0.19p0.19p0.18p847,709
0.19p0.000.0%0.19p0.20p0.18p1,837,603
0.19p0.000.0%0.19p0.20p0.16p4,550,591
0.19p0.000.0%0.19p0.19p0.183p1,885,000
0.19p0.000.0%0.19p0.19p0.18p8,693
0.19p-0.005-2.6%0.19p0.19p0.18p4,343,309
0.195p0.000.0%0.195p0.20p0.19p6,160,513
0.195p0.000.0%0.195p0.195p0.191p1,572,044
0.195p0.000.0%0.195p0.20p0.192p1,685,618
0.195p0.000.0%0.195p0.197p0.195p1,125,000
0.195p-0.005-2.5%0.20p0.21p0.19p10,361,974
0.20p0.000.0%0.20p0.21p0.19p818,014
0.20p0.000.0%0.20p0.21p0.192p439,961
0.20p0.000.0%0.20p0.20p0.20p1,730,189
0.20p0.000.0%0.20p0.21p0.191p1,731,492
0.20p0.000.0%0.20p0.21p0.19p30,837
0.20p+0.005+2.6%0.195p0.21p0.191p2,129,578
0.195p0.000.0%0.195p0.20p0.195p36,153
0.195p0.000.0%0.195p0.20p0.19p1,550
Ticker
LSE:TCF
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LSE
Currency
GBX

What changed lately

Calls

Replays

  • Theracryf (LSE:TCF) — Update on the Ox-1 programme

    Tue, Oct 20, 2026 · 8:00 AM ET

    Watch Transcript

  • Theracryf (LSE:TCF) — Final Results for the year ended 31 March 2026

    Mon, Sep 28, 2026 · 8:00 AM ET

    Watch Transcript

  • Theracryf (LSE:TCF) — Investor Presentation

    Fri, Apr 24, 2026 · 5:00 AM ET

    Watch Transcript

Latest news

Result of Annual General Meeting

Oct 22, 2026

Closed 0.175p (-2.8%) on Oct 22, 2026

Ox-1 Preclinical Data Package Complete

Oct 19, 2026

Closed 0.18p (+2.9%) on Oct 19, 2026

Holding(s) in Company

Oct 13, 2026

Closed 0.175p (-2.8%) on Oct 13, 2026

Change of Nominated Adviser

Oct 9, 2026

Closed 0.17p (-5.6%) on Oct 9, 2026

Australian partner to progress Ox-1 Phase 1 trial

Oct 2, 2026

Closed 0.18p (0.0%) on Oct 2, 2026

Posting of Annual Report and Notice of AGM

Sep 30, 2026

Closed 0.18p (+2.9%) on Sep 30, 2026

Final Results for the year ended 31 March 2026

Sep 28, 2026

Closed 0.17p (0.0%) on Sep 28, 2026

Notice of Results and Investor Presentation

Sep 14, 2026

Closed 0.185p (0.0%) on Sep 14, 2026

Proposed Placing & Subscription to raise £1.05m

Aug 20, 2026

Closed 0.19p (0.0%) on Aug 21, 2026

Positive Ox-1 tox data in addiction programme

May 14, 2026

Closed 0.245p (+11.4%) on May 14, 2026

All TheraCryf PLC news

Financings

  • Private placement of new ordinary shares (Placing Shares and Subscription Shares)

    Aug 20, 2026 · US$1.43M

    Announced: about £1.05M · GBX 0.18 a share · Turner Pope +1

    Dealers: Turner Pope (lead), Singer Capital Markets (co-lead)

    Buyers: Northern Standard Limited (138,888,888 Subscription Shares; 20.8% of Enlarged Share Capital following Admission); Dr Huw Jones (5,555,555 Subscription Shares); Toni Haenninen (via Borealito GmbH) (4,444,444 Subscription Shares); Dr Alastair Smith (13,888,888 Subscription Shares); Dr Nicholas Mallard (2,777,777 Subscription Shares); Dr Glen Clack (1,388,888 Subscription Shares); Dr Helen Kuhlman (3,333,333 shares)

    Insiders: Certain PDMRs to subscribe for an aggregate 28,055,552 New Ordinary Shares through the PDMR Subscription

    Use of proceeds: Complete clinic-enabling programme for Ox-1 addiction asset, apply for Phase 1 approval in Australia, and extend cash runway to end Q1 2027

    Announced Aug 20, 2026

Read by 6ix AI from the company's releases

Decks

TheraCryf PLC on 6ix

Sector
Health care
Industry
Biotechnology
News releases
22 in the last 12 months · 234 in all · newest Oct 22, 2026 · oldest 2007
Calls
12 calls with a replay · 12 with a transcript · latest Oct 20, 2026
Decks
15 decks · latest Sep 7, 2026

Where TheraCryf PLC is listed

ListingExchangeCountryCurrency
LSE:TCF · Home listing · This pageLSEUnited KingdomGBX
Frankfurt:8EVFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about TheraCryf PLC.